Scatter correction for contrast-enhanced digital breast tomosynthesis with a dual-layer detector.

J Med Imaging (Bellingham)

Stony Brook Medicine, Department of Radiology, Stony Brook, New York, United States.

Published: January 2025

Purpose: Contrast-enhanced digital breast tomosynthesis (CEDBT) highlights breast tumors with neo-angiogenesis. A recently proposed CEDBT system with a dual-layer (DL) flat-panel detector enables simultaneous acquisition of high-energy (HE) and low-energy (LE) projection images with a single exposure, which reduces acquisition time and eliminates motion artifacts. However, x-ray scatter degrades image quality and lesion detectability. We propose a practical method for accurate and robust scatter correction (SC) for DL-CEDBT.

Approach: The proposed hybrid SC method combines the advantages of a two-kernel iterative convolution method and an empirical interpolation strategy, which accounts for the reduced scatter from the peripheral breast region due to thickness roll-off and the scatter contribution from the region outside the breast. Scatter point spread functions were generated using Monte Carlo simulations with different breast glandular fractions, compressed thicknesses, and projection angles. Projection images and ground truth scatter maps of anthropomorphic digital breast phantoms were simulated to evaluate the performance of the proposed SC method and three other kernel- and interpolation-based methods. The mean absolute relative error (MARE) between scatter estimates and ground truth was used as the metric for SC accuracy.

Results: DL-CEDBT shows scatter characteristics different from dual-shot, primarily due to the two energy peaks of the incident spectrum and the structure of the DL detector. Compared with the other methods investigated, the proposed hybrid SC method showed superior accuracy and robustness, with MARE of for all LE and HE projection images of different phantoms in both cranial-caudal and mediolateral-oblique views. After SC, cupping artifacts in the dual-energy image were removed, and the signal difference-to-noise ratio was improved by 82.0% for 8 mm iodine objects.

Conclusions: A practical SC method was developed, which provided accurate and robust scatter estimates to improve image quality and lesion detectability for DL-CEDBT.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11615639PMC
http://dx.doi.org/10.1117/1.JMI.12.S1.S13008DOI Listing

Publication Analysis

Top Keywords

digital breast
12
projection images
12
scatter
10
scatter correction
8
contrast-enhanced digital
8
breast tomosynthesis
8
image quality
8
quality lesion
8
lesion detectability
8
practical method
8

Similar Publications

A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2- breast cancer-FINEST study.

Cancer Commun (Lond)

January 2025

Department of Breast Surgery, Key Laboratory of Breast Cancer in Shanghai, Fudan University Shanghai Cancer Centre, Shanghai, P. R. China.

Background: Hormone receptor-positive (HR+)/humaal growth factor receptor 2-negative (HER2-) breast cancer, the most common breast cancer type, has variable prognosis and high recurrence risk. Neoadjuvant therapy is recommended for median-high risk HR+/HER2- patients. This phase II, single-arm, prospective study aimed to explore appropriate neoadjuvant treatment strategies for HR+/HER2- breast cancer patients.

View Article and Find Full Text PDF

Plasma cell-free DNA (cfDNA) analysis to track estrogen receptor 1 (ESR1) mutations is highly beneficial for the identification of tumor molecular dynamics and the improvement of personalized treatments for patients with metastatic breast cancer (MBC). Plasma-cfDNA is, up to now, the most frequent liquid biopsy analyte used to evaluate ESR1 mutational status. Circulating tumor cell (CTC) enumeration and molecular characterization analysis provides important clinical information in patients with MBC.

View Article and Find Full Text PDF

Background: In a world confronted with new and connected challenges, novel strategies are needed to help children and adults achieve their full potential, to predict, prevent and treat disease, and to achieve equity in services and outcomes. Australia's Generation Victoria (GenV) cohorts are designed for multi-pronged discovery (what could improve outcomes?) and intervention research (what actually works, how much and for whom?). Here, we describe the key features of its protocol.

View Article and Find Full Text PDF

Objectives: This study aimed to investigate patients' use of electronic Patient-Reported Outcome Measures (ePROMs) and understand the demographic and clinical factors that may be correlated with patient responses to the BREAST-Q at the preoperative stage of breast cancer. The BREAST-Q is a PROM in questionnaire format, developed and validated to assess satisfaction and quality of life for breast surgery patients.The hypothesis tested is that considering disparities in geography, age and education among responders is essential for capturing a diverse patient population in future Patent-Reported Outcome Measures initiatives, examining how these characteristics are associated with Patent-Reported Outcome Measures utilisation and outcomes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!